Matsui H, Arai Y, Imoto H, et al. Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT. Blood Adv. 2020;4(13):3169-3179.

In the left column on page 3173, in the paragraph that begins “Regarding response to TA-TMA treatment,” “serum lactate dehydrogenase levels or fragment red blood cells” should read “serum lactate dehydrogenase levels and fragment red blood cells.”

This error does not affect the study's findings or conclusions.